Aziyo Biologics (ELUT) Stock Statistics & Valuation Metrics

Aziyo Biologics has a market cap or net worth of $72.36M. The enterprise value is $243.89M.

Aziyo Biologics has 36,802,258 shares outstanding. The number of shares has decreased by -2.65% in one year.

Aziyo Biologics’s return on equity (ROE) is 1.17 and return on invested capital (ROIC) is -84894.31%.

The current PE Ratio of Aziyo Biologics is -2.02. Aziyo Biologics’s PEG ratio is 0.00.

In the last 12 months, Aziyo Biologics had revenue of 24.38M and earned -53.95M in profits. Earnings per share was -1.86.

In the last 12 months, operating cash flow was -28.90M and capital expenditures -357.00K, giving a free cash flow of -29.25M billion.

Aziyo Biologics pays an annual dividend of ―, resulting in a dividend yield of ―

Aziyo Biologics upcoming earnings date is Aug 6, 2025, TBA Not Confirmed.

Aziyo Biologics as a current ratio of 0.69, with Debt / Equity ratio of -782.79%

In the past 12 months, Aziyo Biologics has paid 7.00K in taxes.

Aziyo Biologics EV to EBITDA ratio is -2.74, with an EV/FCF ratio of -5.39.

Aziyo Biologics has $17.36M in cash and marketable securities with $29.43M in debt, giving a net cash position of $12.07M billion.

Gross margin is 48.80%, with operating margin of -146.26%, and net profit margin of -221.33%.

The average price target for Aziyo Biologics is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy